Nuelle

NeuroRX

This company develops small molecule medicines for patients with central nervous system disorders, such as suicidal bipolar depression and post-traumatic stress disorder.

nupathe-pharma

This company develops transdermal patches and biodegradable implants to deliver medication for central nervous system disorders like migraines and Parkinson's disease.

nextwave-pharmaceuticals

This company develops and commercialises extended-release liquid and chewable medicines for patients with attention deficit hyperactivity disorder and other central nervous system conditions.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Neuro3D SA

This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Kasvu Therapeutics

This company develops small-molecule neuroplastogen treatments for neuropsychiatric and neurodegenerative disorders, targeting patients with major depressive disorder and brain diseases.

ProNovo Therapeutics

This biotechnology company develops precision pharmaceutical treatments for patients with neuropsychiatric conditions, such as major depressive disorder and schizophrenia.